Research     Digg This!     Facebook     Google     Reddit     Stumble It!
title Filter     Display # 
# Article Title Author
1 03/10/2010 Press Release: "Unraveling the Mystery Behind HIV/AIDS", Singapore Agency for Science, Technology and Research webmaster
2 2/26/10 Science Daily: "Innate Mechanisms Can Control Disease Progression in HIV-Positive Patients", Barcelona, Spain research findings on dendritic cell webmaster
3 Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV (Abstract) Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D
4 Elite control of HIV infection: implications for vaccine design (Summary) BM Baker‌, BL Block‌, AC Rothchild‌ & BD Walker‌
5 Elite HIV controllers: myth or reality? (Abstract) Saksena NK, Rodes B, Wang B, Soriano V
6 Potential Mechanism of Long Term Control of HIV Elizabeth Reay
7 Handful of 20-year HIV survivors hold key to discovering vaccine Steve Connor, Independent Science Editor
8 Antibodies Present in Long-Term HIV Survivors Could Contribute to Vaccine Development, Study Says Kaiser Network
9 Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals webmaster
10 Potential Reason Why LTNPs Are Healthy Elizabeth Reay
11 Well- Armed Immune Cells Help LTNPs Contain HIV Loreen Willenberg
12 Recovery of Viremic Control after Superinfection with Pathogenic HIV Type 1 in a Long-Term Elite Controller of HIV Type 1 Infection Loreen Willenberg

Please Donate!

Please make a tax deductible donation to Zephyr LTNP Foundation, a 501(c)(3) entity via Paypal. No Paypal account required.

CROI 2011

  • Wednesday 9th March 2011
    This is our final bulletin from CROI 2011. We hope you have found our news coverage useful. You can find all our coverage at, including the news reports and bulletins.We are always looking for ways of improving and developing our resources – so if you have any comments that you would like
  • Thursday 3rd March 2011
    There is increasing evidence of the transmission of HIV strains with resistance to anti-HIV drugs in low- and middle-income countries. Research in eleven sub-Saharan African countries showed that the chances of detecting transmitted resistance increased by over a third each year that a country had been scaling up HIV treatment. A separate study involving people recently diagnosed
  • Wednesday 2nd March 2011
    A new type of anti-HIV drug that targets the first step in HIV’s entry into cells has done well in a Phase IIa study. Currently known as BMS-663068, the drug was shown to be safe and to work against the virus. HIV cell entry is a three-step process. The virus must first attach to the

Follow Us

  • Facebook Page:
  • Twitter: zephyrfound
  • YouTube: zephyrfoundation

Controllers in Study

 Donation Thermometer
 Donation Thermometer
 Donation Thermometer

Our Goal:
December 30, 2009

Current Breakdown: 505 Elite Controllers 1009 Viremic Controllers 211 Other